rts logo

Are we looking at the next big move in Tempest Therapeutics Inc (TPST)?

Tempest Therapeutics Inc (NASDAQ: TPST) is -75.00% lower on its value in year-to-date trading and has touched a low of $0.92 and a high of $6.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TPST stock was last observed hovering at around $1.10 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $1.10, the stock is -6.48% and -14.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.69 million and changing 0.00% at the moment leaves the stock -58.73% off its SMA200. TPST registered -73.93% loss for a year compared to 6-month loss of -68.30%. The firm has a 50-day simple moving average (SMA 50) of $1.2797 and a 200-day simple moving average (SMA200) of $2.665385.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -21.43% gain in the last 1 month and extending the period to 3 months gives it a -38.20%, and is 4.76% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.52% over the week and 13.08% over the month.

Tempest Therapeutics Inc (TPST) has around 17 employees, a market worth around $27.73M and $0.00M in sales. Distance from 52-week low is 19.55% and -81.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-114.99%).

The EPS is expected to grow by 22.35% this year.

Tempest Therapeutics Inc (TPST) Top Institutional Holders

28.0 institutions hold shares in Tempest Therapeutics Inc (TPST), with institutional investors hold 22.49% of the company’s shares. The shares outstanding are 22.05M, and float is at 21.19M with Short Float at 17.56%. Institutions hold 22.43% of the Float.

The top institutional shareholder in the company is BLACKROCK INC. with over 0.55 million shares valued at $1.21 million. The investor’s holdings represent 2.4747% of the TPST Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 0.43 million shares valued at $0.95 million to account for 1.9426 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.18 million shares representing 0.7924% and valued at over $0.39 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.6937 of the shares totaling 0.15 million with a market value of $0.34 million.

Tempest Therapeutics Inc (TPST) Insider Activity

#####

Tempest Therapeutics Inc disclosed in a document filed with the SEC on Aug 08 ’24 that Versant Venture Capital VI, L. (10% Owner) sold a total of 400,000 shares of the company’s common stock. The trade occurred on Aug 08 ’24 and was made at $1.35 per share for $0.54 million. Following the transaction, the insider now directly holds 0.6 million shares of the TPST stock.

Still, SEC filings show that on Aug 12 ’24, Versant Venture Capital VI, L. (10% Owner) disposed off 387,999 shares at an average price of $1.10 for $0.43 million. The insider now directly holds 209,941 shares of Tempest Therapeutics Inc (TPST).

Related Posts